This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
Biologics and biosmiliars
This page is a summary of: Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives, Journal of Inflammation Research, May 2018, Dove Medical Press,
DOI: 10.2147/jir.s165330.
You can read the full text:
The following have contributed to this page
Clinical Journal of the American Society of Nephrology
Immune checkpoint inhibitor (ICI) use in kidney transplant patients is complicated by high rates of allograft rejection. ICI-associated T-cell mediated rejection (ICI-TCMR) is a novel, poorly under...
Stem Cells International
The manuscript explains that humans and animals lose tissues and organs due to several reasons. In addition, our bodies have a low regenerative potential meaning that once lost some tissues and org...
Journal of Oncology
Because the pattern of gene expression in differentiated tissues is regulated by gene silencing, a process involving alterations to DNA and histone structure, it is important to preserve this chrom...
